Nabumetone

This classification denotes a nonsteroidal antiinflammatory drug and naphthalene compound with the molecular formula C15H16O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LW0TIW155Z, chemically known as 2-butanone, 4-(6-methoxy-2-naphthalenyl)- but generally known as nabumetone, which bears US NIH Compound Identifier 4409. European Medicines Agency schedules Nabumetone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09107MIG. The term NABUMETONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules nabumetone in its Anatomical Therapeutic Chemical (ATC) Classification. NABUMETONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nabumetone under HS 29145000 and SITC 51629. As of Q4 2014, NABUMETONE remains the US FDA Preferred Term for this commodity. Nabumetone bears US NLM identifiers UMLS ID C0701331 and NCI Concept Code C47627. SMILES: O(C1CC2C(CC(CCC(=O)C)CC2)CC1)C.